好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Multiple Sclerosis: Immunology III

Thursday 04/30/09
01:30 PM - 03:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
MS and Related Diseases
No CME available
Event Timeline
01:30 PM - 03:30 PM Abstract 001 - Targeting CNS-Autoimmunity and [ndash]Repair Using the Secretory Leukocyte Protease Inhibitor (SLPI)
01:30 PM - 03:30 PM Abstract 002 - Inhibition of GAPDH Activity and Induction of Neuronal Apoptosis and Axonal Degeneration by Antibodies Present in the Cerebrospinal Fluid and Brain Tissue of Patients with Multiple Sclerosis
01:30 PM - 03:30 PM Abstract 003 - The Immunomodulator Fingolimod (FTY720) Increases Myelin Production Following Demyelination of Organotypic Cerebellar Slices
01:30 PM - 03:30 PM Abstract 004 - Fish Diet Prevents Demyelination, Clinical Symptoms and MRI Activity in the Cuprizone Model
01:30 PM - 03:30 PM Abstract 005 - Capacity of Human Fetal Oligodendrocyte Progenitors To Differentiate and Ensheath Axons in Response to Growth Factors
01:30 PM - 03:30 PM Abstract 006 - Whole Genome Analysis of the Effect of Interferon-beta Treatment on Different Peripheral Blood Cell Populations in Multiple Sclerosis Patients
01:30 PM - 03:30 PM Abstract 008 - The Effect of Laquinimod on Lymphocyte VLA-4 Properties under Shear Flow Conditions
Faculty Disclosures
Bibiana Bielekova, MD, FAAN Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Alexandre Prat, MD The institution of Dr. Prat has received research support from CIHR and MSSC.
Michael Demetriou, MD, PhD Dr. Demetriou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Demetriou has stock in GlyTR Therapeutics. Dr. Demetriou has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
James T. Becker, PhD No disclosure on file
Xiaosong Zhao, MD No disclosure on file
Andreas Steinbrecher, MD No disclosure on file
Mauricio Farez No disclosure on file
Oivind Torkildsen No disclosure on file
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Guillermo Izquierdo Ayuso, MD Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Samuel Ludwin, MD No disclosure on file
Neal S. Hermanowicz, MD, FAAN No disclosure on file
Peter Darlington, PhD No disclosure on file
Francisco J. Quintana, PhD Dr. Quintana has nothing to disclose.
Qiao Ling Cui, MD No disclosure on file
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Antonio H. Iglesias, MD Dr. Iglesias has nothing to disclose.
Veronique Miron No disclosure on file
Kjell Morten Myhr, MD No disclosure on file
Andre M. Mueller, PhD No disclosure on file
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Stanley van den Noort, MD No disclosure on file
Yufen Qin, MD No disclosure on file
Gaby T. Thai, MD, FAAN Dr. Thai has nothing to disclose.
Yiping Zhang No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
M. I. Kamboh No disclosure on file
Sarah Berman, MD The institution of Dr. Berman has received research support from NIH.
Robert A. Sweet Robert A. Sweet has nothing to disclose.
Alexis M. Steinberg, MD The institution of Dr. Steinberg has received research support from University of Pittsburgh Clinical and Translational Institute (CTSI).
Sonia Kumari, MBBS No disclosure on file